Advertisement Artemis Health names new senior vice president of R&D - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Artemis Health names new senior vice president of R&D

Artemis Health, a developer of non-invasive prenatal diagnostic tests, has appointed Richard Rava as its new senior vice president of R&D.

Dr Rava comes to Artemis after 16 years at Affymetrix where he was a scientific co-founder and most recently senior vice president of R&D. Dr Rava has received his BA and PhD in chemistry from Rutgers University.

Lissa Goldenstein, president and CEO of Artemis Health, said: “Rich’s depth and breadth of research, development and manufacturing experience, together with his proven track record in commercializing genetic analysis tools, makes him uniquely suited to lead our efforts to bring non-invasive prenatal diagnostic tests to the market.”